( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
123.6
121.7
124.6
124.9
Total Expenditure
147.3
142.7
144.5
160.3
PBIDT (Excl OI)
-23.7
-21
-19.9
-35.4
Other Income
61.2
59.6
58.2
64.5
Operating Profit
37.5
38.6
38.3
29.1
Exceptional Items
NA
NA
NA
NA
Profit Before Tax
34
35.1
34.7
25.5
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
25.9
25.8
25.6
25
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Minority Interest
NA
NA
NA
NA
Shares of Associates
4.2
4.8
5.4
7
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
30.1
30.6
31
32
Equity Capital
151
151
151
151
Face Value (IN RS)
10
10
10
10
Calculated EPS
1.99
2.02
2.05
2.11
Calculated EPS (Annualised)
7.97
8.10
8.21
8.47
No of Public Share Holdings
8239936
8239936
8239936
8239936
% of Public Share Holdings
54.57
54.57
54.57
54.57
PBIDTM% (Excl OI)
-19.17
-17.25
-15.97
-28.34
PBIDTM%
30.33
31.71
30.73
23.29
PBDTM%
30.33
31.71
30.73
23.29
PBTM%
27.50
28.84
27.84
20.41
PATM%
20.95
21.19
20.54
20.01